BioGenerator’s team offers diverse scientific, entrepreneurial, and business experience. Our bullpen of talented Executives in Residence and Venture Capital Fellows work closely with BioGenerator staff in building and scaling new companies, cycling in and out of roles in projects and portfolio companies. Commercialization centers focus resources in specific industry sectors. The BioGenerator Ventures team manages investment activity and the BioGenerator Ventures portfolio. BioSTL is BioGenerator's parent company.
“The St. Louis startup community is flourishing. We’ve discovered and invested in several of our most promising companies there. I continue to be impressed by the BioGenerator model and the quality of their portfolio.”
Co-Founder and CSO, Confluence (NASDAQ:ACRS)
“BioGenerator was deeply committed to working with the founders to build a successful company. Without the ongoing support of BioGenerator, the Confluence story would never have happened.
Partner, Jump Capital
“We were impressed with the companies in the BioGenerator, and identified a strong opportunity for Jump Capital to add to our portfolio.”
Managing Director, Middleland Capital
“BioGenerator’s model has helped grow companies like Benson Hill into quality, highly-attractive investments for venture investors.”
Co-Founder and CMO, SentiAR
“BioGenerator has been instrumental in launching our company—from learning how to be successful academic founders to the details of starting and financing SentiAR, our spin out from Washington University. They have made crucial introductions to industry leaders at appropriate times and invested in our company. We could not have embarked down this path without all the support from the BioGenerator team!”
VC Fellow at BioGenerator and Head of Product at Readout Health
“Readout Health’s founders came to BioGenerator with a promising concept in early 2019, and by the end of the year we’d built a strong new business and launched our first product. BioGenerator quickly deployed talent from its Entrepreneur in Residence and Venture Capital Fellows programs, along with pre-investment grant funding, to help launch Readout Health.”
Co-Founder and CSO, DiSARM Therapeutics (NYSE:LLY)
“BioGenerator helped us immensely by providing critical pre-company proof of concept funding, advice, and connections as we launched our new company. Their relationships with venture capital and experience structuring deals were invaluable in this process.”
VC Fellow at BioGenerator; VP Finance and Operations at Wugen
“My role as a BioGenerator Venture Capital Fellow exposed me to many startup opportunities as I explored the business aspects of commercializing technology. I quickly recognized the potential significance of Wugen’s technology and am excited to be part of the Wugen team as we advance forward into clinical trials.”